Loading company
Addex Therapeutics Ltd.
ADXN · Nasdaq · Healthcare · Biotechnology
$3.65+5.5%Sep 25 close
- 1M
- -4.9%
- 6M
- -45.5%
- 1Y
- -59.2%
- 5Y
- -98.1%
ADXN · Nasdaq · Healthcare · Biotechnology
$3.65+5.5%Sep 25 close
The quarter ending June 30, 2025, against the same quarter a year earlier.
| Measure | 3 months toJun 30, 2025 | 3 months toJun 30, 2023 | Change |
|---|---|---|---|
| Profit | -$2.2M | -$3.2M | +31.18% |
| Profit per share | -$0.02 | -$0.17 | +85.71% |
| Free Cash Flow | -$2.7M | -$3.1M | +11.95% |
These are single quarters, not a trailing year — the figures elsewhere on this site cover twelve months and will be much larger. A seasonal business swings a long way between the two: ServiceNow earns $2.0B of free cash flow in its December quarter and $0.5B in its June one.
Compared against the same quarter a year earlier, not against an analyst forecast. A “beat” or “miss” needs a consensus estimate, which is licensed data we do not carry — and getting it wrong is worse than leaving it out.
Addex Therapeutics Ltd. has no earnings call transcript available.